277 related articles for article (PubMed ID: 26437027)
21. LINX
Skubleny D; Switzer NJ; Dang J; Gill RS; Shi X; de Gara C; Birch DW; Wong C; Hutter MM; Karmali S
Surg Endosc; 2017 Aug; 31(8):3078-3084. PubMed ID: 27981382
[TBL] [Abstract][Full Text] [Related]
22. Two-year results of intermittent electrical stimulation of the lower esophageal sphincter treatment of gastroesophageal reflux disease.
Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oxenberg D; Perez-Castilla A; Netto MG; Soffer E; Boscardin WJ; Crowell MD
Surgery; 2015 Mar; 157(3):556-67. PubMed ID: 25726315
[TBL] [Abstract][Full Text] [Related]
23. The LINX® reflux management system: confirmed safety and efficacy now at 4 years.
Lipham JC; DeMeester TR; Ganz RA; Bonavina L; Saino G; Dunn DH; Fockens P; Bemelman W
Surg Endosc; 2012 Oct; 26(10):2944-9. PubMed ID: 22538694
[TBL] [Abstract][Full Text] [Related]
24. Magnetic sphincter augmentation is an effective treatment for atypical symptoms caused by gastroesophageal reflux disease.
Ward MA; Ebrahim A; Kopita J; Arviso L; Ogola GO; Buckmaster B; Leeds SG
Surg Endosc; 2020 Nov; 34(11):4909-4915. PubMed ID: 31792691
[TBL] [Abstract][Full Text] [Related]
25. Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease.
Schwameis K; Nikolic M; Morales Castellano DG; Steindl A; Macheck S; Kristo I; Zörner B; Schoppmann SF
World J Surg; 2018 Oct; 42(10):3263-3269. PubMed ID: 29619511
[TBL] [Abstract][Full Text] [Related]
26. Clinical Outcomes and Predictors of Favorable Result after Laparoscopic Magnetic Sphincter Augmentation: Single-Institution Experience with More than 500 Patients.
Ayazi S; Zheng P; Zaidi AH; Chovanec K; Salvitti M; Newhams K; Hoppo T; Jobe BA
J Am Coll Surg; 2020 May; 230(5):733-743. PubMed ID: 32081749
[TBL] [Abstract][Full Text] [Related]
27. [Preliminary results of Chinese magnetic sphincter augmentation in treating gastroesophageal reflux disease].
Sun YF; Jiang HY; Gu HY; He Y; Yang Y; Zhang XB; Yang Y; Hua R; Guo XF; Ye B; Mao T; Li ZG
Zhonghua Wai Ke Za Zhi; 2020 Sep; 58(9):691-696. PubMed ID: 32878416
[No Abstract] [Full Text] [Related]
28. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
[TBL] [Abstract][Full Text] [Related]
29. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
30. Magnetic sphincter augmentation with the LINX device for gastroesophageal reflux disease after U.S. Food and Drug Administration approval.
Reynolds JL; Zehetner J; Bildzukewicz N; Katkhouda N; Dandekar G; Lipham JC
Am Surg; 2014 Oct; 80(10):1034-8. PubMed ID: 25264655
[TBL] [Abstract][Full Text] [Related]
31. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
[TBL] [Abstract][Full Text] [Related]
32. Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease.
Lipham JC; Taiganides PA; Louie BE; Ganz RA; DeMeester TR
Dis Esophagus; 2015; 28(4):305-11. PubMed ID: 24612509
[TBL] [Abstract][Full Text] [Related]
33. Hiatal hernia recurrence following magnetic sphincter augmentation and posterior cruroplasty: intermediate-term outcomes.
Rona KA; Tatum JM; Zehetner J; Schwameis K; Chow C; Samakar K; Dobrowolsky A; Houghton CC; Bildzukewicz N; Lipham JC
Surg Endosc; 2018 Jul; 32(7):3374-3379. PubMed ID: 29340828
[TBL] [Abstract][Full Text] [Related]
34. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later.
Noar M; Squires P; Noar E; Lee M
Surg Endosc; 2014 Aug; 28(8):2323-33. PubMed ID: 24562599
[TBL] [Abstract][Full Text] [Related]
35. Introduction of mechanical sphincter augmentation for gastroesophageal reflux disease into practice: early clinical outcomes and keys to successful adoption.
Smith CD; DeVault KR; Buchanan M
J Am Coll Surg; 2014 Apr; 218(4):776-81. PubMed ID: 24529809
[TBL] [Abstract][Full Text] [Related]
36. Early results of magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: Systematic review and meta-analysis.
Aiolfi A; Asti E; Bernardi D; Bonitta G; Rausa E; Siboni S; Bonavina L
Int J Surg; 2018 Apr; 52():82-88. PubMed ID: 29471155
[TBL] [Abstract][Full Text] [Related]
37. Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy.
Hatlebakk JG; Zerbib F; Bruley des Varannes S; Attwood SE; Ell C; Fiocca R; Galmiche JP; Eklund S; Långström G; Lind T; Lundell LR;
Clin Gastroenterol Hepatol; 2016 May; 14(5):678-85.e3. PubMed ID: 26226096
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of Magnetic Sphincter Augmentation Across the Spectrum of GERD Disease Severity.
Schwameis K; Ayazi S; Zheng P; Grubic AD; Salvitti M; Hoppo T; Jobe BA
J Am Coll Surg; 2021 Mar; 232(3):288-297. PubMed ID: 33387623
[TBL] [Abstract][Full Text] [Related]
39. Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial.
Bonavina L; Saino GI; Bona D; Lipham J; Ganz RA; Dunn D; DeMeester T
J Gastrointest Surg; 2008 Dec; 12(12):2133-40. PubMed ID: 18846406
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic full-thickness plication (Plicator) with two serially placed implants improves esophagitis and reduces PPI use and esophageal acid exposure.
von Renteln D; Brey U; Riecken B; Caca K
Endoscopy; 2008 Mar; 40(3):173-8. PubMed ID: 18322871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
